T1	Participants 14 83	endocrine and radiation therapy in locally advanced prostatic cancer.
T2	Participants 85 318	151 patients with locally advanced prostatic cancer (T3-4 M0), representing 38% of the 404 cancer patients in a Finnish multicenter study, were randomly assigned to one of three treatment arms: orchiectomy, estrogens or radiotherapy.
